Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes. - Wikidata - awgldk - TriplyDB

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.

http://www.wikidata.org/entity/Q37118963

about

Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra Febrile infection-related epilepsy syndrome treated with anakinra Pharmacological treatment options for cryopyrin-associated periodic syndromes.Interleukin-1 Blockade: An Update on Emerging Indications.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.Muckle-Wells syndrome: clinical perspectives.[Efficacy and safety analysis of off-label treatment with biologics in autoinflammatory diseases : Experiences from a German registry (GRAID2)].Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature.Inflammasomes in Tissue Damages and Immune Disorders After Trauma Anakinra Therapy for Non-cancer Inflammatory Diseases

P2860

Q33817997-86EA42B1-08F5-4CB7-BE3F-19B87DDDA868 Q37579506-7EA8F7EE-E41F-422F-814E-CE5B0530EECB Q38674213-988419AC-F62C-4BF6-A665-BFC7FFB2F043 Q39301613-7BDCE108-4352-437F-B23B-694F01D27008 Q39403443-5822B493-1849-4885-8ACB-30FE423B128E Q39458288-C4643E44-C768-46C8-9278-720709F389A2 Q40053587-B6AD9351-75EC-4659-974E-D23D6458CC36 Q40057989-CFBA0E0B-F61C-4EBF-9795-3EF5C35867F0 Q49574128-BA1F0237-0C03-490B-A94C-6FCA6A648E7F Q58773658-6CBBAB44-28F8-4B5B-AE01-5D173238F3EF Q59136398-AEC0F509-D8B3-4F4E-9139-194EAE498516

P2860

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.

http://www.wikidata.org/entity/Q37118963

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term safety profile of an ...... associated periodic syndromes.

@en

Long-term safety profile of an ...... associated periodic syndromes.

@nl

type

label

Long-term safety profile of an ...... associated periodic syndromes.

@en

Long-term safety profile of an ...... associated periodic syndromes.

@nl

prefLabel

Long-term safety profile of an ...... associated periodic syndromes.

@en

Long-term safety profile of an ...... associated periodic syndromes.

@nl

P1433

Q37118963-B69E8087-BA0D-4C88-92C2-5C9786DDBA53

P1476

Q37118963-75E838C1-EBA4-4258-B3B6-0FCF7B5B3F56

P2093

Q37118963-04BC4B96-16C0-4E40-A815-556A9CA95D44

Q37118963-2C32D64E-CF82-4B03-8339-F891BAAC9F4A

Q37118963-3EA7F401-31B4-43A8-89D6-198B38E9475C

Q37118963-66BEF427-F5E7-4D72-A61E-C9990CE18A4A

Q37118963-D291439B-B512-4E22-851B-791A7EB7798F

P2860

Q37118963-035A26D9-F74C-43B3-8C01-F04A53C7D191

Q37118963-13A9C376-86C4-497C-8F46-8673F23E112E

Q37118963-259466C6-9226-4D2B-B64F-76FBABE250CC

Q37118963-27E0E100-1660-4E4E-BA6A-33FFED8A7C73

Q37118963-3E75809E-4E45-4E83-9E18-B392D43110BB

Q37118963-4681662B-2D9E-427B-887E-42221CFACBBD

Q37118963-5D4299C5-58C7-4FFB-A97B-F72F23A76950

Q37118963-67098AAA-B8FE-46CF-99C3-2EE19172F69E

Q37118963-6FD4450E-C045-4C4C-9D05-C77593E15C32

Q37118963-75D9DA67-4B55-4418-B88B-3B905126F866

P304

Q37118963-3DEBCA00-02CC-4AC9-ADE3-EE2A5B8F3167

P31

Q37118963-BC83FBCD-004B-4C1E-8AA6-A26CB31A0589

P356

Q37118963-61E93895-BCB8-4FC5-ADE4-C66DA12FA9EA

P433

Q37118963-4B63C908-4DB3-49E8-8964-CBFD31BD0639

P478

Q37118963-029D4FE2-C21C-44E5-B862-8D269E9B3DD9

P577

Q37118963-5859F1EB-311A-426B-A11C-880C3B858568

P698

Q37118963-B4BB7178-13CF-45A3-AC74-34435843CD2E

P932

Q37118963-711376A7-F2D6-42A8-AF96-12FD8124E6D2

P356

P1433

P1476

Long-term safety profile of an ...... associated periodic syndromes.

@en

P2093

Hans Olivecrona

http://www.w3.org/2001/XMLSchema#string

Malin Löfqvist

http://www.w3.org/2001/XMLSchema#string

Mika Leinonen

http://www.w3.org/2001/XMLSchema#string

Raphaela Goldbach-Mansky

http://www.w3.org/2001/XMLSchema#string

Torbjörn Kullenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Anakinra for rheumatoid arthritis

Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.

The inflammasome: first line of the immune response to cell stress.

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Anakinra for rheumatoid arthritis: a systematic review.

The emerging role of interleukin-1β in autoinflammatory diseases.

P304

1499-1506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEW208

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27143789

http://www.w3.org/2001/XMLSchema#string

P932

4957676

http://www.w3.org/2001/XMLSchema#string